BIOMAT Database Logo BIOMAT Database Logo

[Activated protein C resistance and mutation of coagulation factor V]. 1996

M M Samama

UI MeSH Term Description Entries
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011486 Protein C A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005165 Factor V Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor V leads to Owren's disease. Coagulation Factor V,Proaccelerin,AC Globulin,Blood Coagulation Factor V,Factor 5,Factor Five,Factor Pi,Factor V, Coagulation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D017354 Point Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation, Point,Mutations, Point,Point Mutations

Related Publications

M M Samama
Mutation in blood coagulation factor V associated with resistance to activated protein C.
May 1994, Nature,
M M Samama
Factor V Cambridge mutation and activated protein C resistance assays.
March 2006, Thrombosis and haemostasis,
M M Samama
Obstetric implications of activated protein C resistance and factor V Leiden mutation.
February 2000, Obstetrical & gynecological survey,
M M Samama
Resistance to activated protein C and a novel factor V gene mutation.
March 1996, Clinics in laboratory medicine,
M M Samama
Coagulation factor V Leiden mutation was detected in the patients with activated protein C resistance in Thailand.
August 1998, Thrombosis and haemostasis,
M M Samama
Resistance to activated protein C caused by a factor V gene mutation.
September 1995, Current opinion in hematology,
M M Samama
Activated protein C resistance caused by factor V gene mutation: common coagulation defect in chronic venous leg ulcers?
April 1997, Journal of the American Academy of Dermatology,
M M Samama
Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease.
February 1995, Lancet (London, England),
M M Samama
[Factor V Leiden and activated protein C resistance].
June 1997, Revue medicale de Bruxelles,
M M Samama
Factor V Leiden and activated protein C resistance.
January 2009, Advances in clinical chemistry,
Copied contents to your clipboard!